These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

891 related articles for article (PubMed ID: 22476196)

  • 21. Insulin protects against Aβ-induced spatial memory impairment, hippocampal apoptosis and MAPKs signaling disruption.
    Ghasemi R; Zarifkar A; Rastegar K; maghsoudi N; Moosavi M
    Neuropharmacology; 2014 Oct; 85():113-20. PubMed ID: 24881967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenovirus-Mediated Transduction of Insulin-Like Growth Factor 1 Protects Hippocampal Neurons from the Toxicity of Aβ Oligomers and Prevents Memory Loss in an Alzheimer Mouse Model.
    Selles MC; Fortuna JTS; Zappa-Villar MF; de Faria YPR; Souza AS; Suemoto CK; Leite REP; Rodriguez RD; Grinberg LT; Reggiani PC; Ferreira ST
    Mol Neurobiol; 2020 Mar; 57(3):1473-1483. PubMed ID: 31760608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin resistance and exendin-4 treatment for multiple system atrophy.
    Bassil F; Canron MH; Vital A; Bezard E; Li Y; Greig NH; Gulyani S; Kapogiannis D; Fernagut PO; Meissner WG
    Brain; 2017 May; 140(5):1420-1436. PubMed ID: 28334990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Linagliptin, a DPP-4 inhibitor, ameliorates Aβ (1-42) peptides induced neurodegeneration and brain insulin resistance (BIR) via insulin receptor substrate-1 (IRS-1) in rat model of Alzheimer's disease.
    Siddiqui N; Ali J; Parvez S; Zameer S; Najmi AK; Akhtar M
    Neuropharmacology; 2021 Sep; 195():108662. PubMed ID: 34119519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adiponectin-mimetic novel nonapeptide rescues aberrant neuronal metabolic-associated memory deficits in Alzheimer's disease.
    Ali T; Rehman SU; Khan A; Badshah H; Abid NB; Kim MW; Jo MH; Chung SS; Lee HG; Rutten BPF; Kim MO
    Mol Neurodegener; 2021 Apr; 16(1):23. PubMed ID: 33849621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exenatide promotes cognitive enhancement and positive brain metabolic changes in PS1-KI mice but has no effects in 3xTg-AD animals.
    Bomba M; Ciavardelli D; Silvestri E; Canzoniero LM; Lattanzio R; Chiappini P; Piantelli M; Di Ilio C; Consoli A; Sensi SL
    Cell Death Dis; 2013 May; 4(5):e612. PubMed ID: 23640454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exendin-4 prevents c-Jun N-terminal protein kinase activation by tumor necrosis factor-alpha (TNFalpha) and inhibits TNFalpha-induced apoptosis in insulin-secreting cells.
    Natalicchio A; De Stefano F; Orlando MR; Melchiorre M; Leonardini A; Cignarelli A; Labarbuta R; Marchetti P; Perrini S; Laviola L; Giorgino F
    Endocrinology; 2010 May; 151(5):2019-29. PubMed ID: 20219981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer's disease.
    Dineley KT; Westerman M; Bui D; Bell K; Ashe KH; Sweatt JD
    J Neurosci; 2001 Jun; 21(12):4125-33. PubMed ID: 11404397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucagon-like peptide-1 decreases endogenous amyloid-beta peptide (Abeta) levels and protects hippocampal neurons from death induced by Abeta and iron.
    Perry T; Lahiri DK; Sambamurti K; Chen D; Mattson MP; Egan JM; Greig NH
    J Neurosci Res; 2003 Jun; 72(5):603-12. PubMed ID: 12749025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuronal Protein Tyrosine Phosphatase 1B Hastens Amyloid β-Associated Alzheimer's Disease in Mice.
    Ricke KM; Cruz SA; Qin Z; Farrokhi K; Sharmin F; Zhang L; Zasloff MA; Stewart AFR; Chen HH
    J Neurosci; 2020 Feb; 40(7):1581-1593. PubMed ID: 31915254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metformin attenuates Alzheimer's disease-like neuropathology in obese, leptin-resistant mice.
    Li J; Deng J; Sheng W; Zuo Z
    Pharmacol Biochem Behav; 2012 Jun; 101(4):564-74. PubMed ID: 22425595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nicotinamide mononucleotide protects against β-amyloid oligomer-induced cognitive impairment and neuronal death.
    Wang X; Hu X; Yang Y; Takata T; Sakurai T
    Brain Res; 2016 Jul; 1643():1-9. PubMed ID: 27130898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic mouse model of Alzheimer's disease.
    Li HQ; Ip SP; Yuan QJ; Zheng GQ; Tsim KKW; Dong TTX; Lin G; Han Y; Liu Y; Xian YF; Lin ZX
    Brain Behav Immun; 2019 Nov; 82():264-278. PubMed ID: 31476414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
    Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W
    Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breviscapine exerts neuroprotective effects through multiple mechanisms in APP/PS1 transgenic mice.
    Li Z; Zhang XB; Gu JH; Zeng YQ; Li JT
    Mol Cell Biochem; 2020 May; 468(1-2):1-11. PubMed ID: 32144518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-diabetes drug pioglitazone ameliorates synaptic defects in AD transgenic mice by inhibiting cyclin-dependent kinase5 activity.
    Chen J; Li S; Sun W; Li J
    PLoS One; 2015; 10(4):e0123864. PubMed ID: 25875370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuronal IGF-1 resistance reduces Abeta accumulation and protects against premature death in a model of Alzheimer's disease.
    Freude S; Hettich MM; Schumann C; Stöhr O; Koch L; Köhler C; Udelhoven M; Leeser U; Müller M; Kubota N; Kadowaki T; Krone W; Schröder H; Brüning JC; Schubert M
    FASEB J; 2009 Oct; 23(10):3315-24. PubMed ID: 19487308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amyloid-beta causes memory impairment by disturbing the JAK2/STAT3 axis in hippocampal neurons.
    Chiba T; Yamada M; Sasabe J; Terashita K; Shimoda M; Matsuoka M; Aiso S
    Mol Psychiatry; 2009 Feb; 14(2):206-22. PubMed ID: 18813209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New Alzheimer's disease model mouse specialized for analyzing the function and toxicity of intraneuronal Amyloid β oligomers.
    Ochiishi T; Kaku M; Kiyosue K; Doi M; Urabe T; Hattori N; Shimura H; Ebihara T
    Sci Rep; 2019 Nov; 9(1):17368. PubMed ID: 31757975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effects of diet- and genetically-induced brain insulin resistance on amyloid pathology in a mouse model of Alzheimer's disease.
    Wakabayashi T; Yamaguchi K; Matsui K; Sano T; Kubota T; Hashimoto T; Mano A; Yamada K; Matsuo Y; Kubota N; Kadowaki T; Iwatsubo T
    Mol Neurodegener; 2019 Apr; 14(1):15. PubMed ID: 30975165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.